Louis Manzo, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 28,384 shares at $3.52 ($100K) on 2015-01-21, disclosed to the SEC on 2015-01-22.
Open-market purchase of $100k CAPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |